Brovina reacts to dangerous insulin only after it was made public: We sent him to Croatia for analysis.

The chairman of the Commission for Health in the Kosovo Assembly, Flora Brovina, has said the biosemilary insulin has been sent to Croatia for quantitative analysis. Brovina, for Insider, has said it is true that big fuss has now taken place, but according to him on the same issue has been debated earlier. She said [...]
The chairman of the Commission for Health in the Kosovo Assembly, Flora Brovina, has said the biosemilary insulin has been sent to Croatia for quantitative analysis.
Brovina, for Insider, has said it is true that big fuss has now taken place, but according to him on the same issue has been debated earlier.
She has said that after the two doctors' complaint, commission members have asked the minister to remove the suspicious insulin.
The guy who wrote it all is real, and we've made it too big and we've gone as a commission to the ministry and told her that insulin should be removed”, she said.
Brovina has indicated that even after the investigation of this risk, he has not been able to escape the risk due to the large container he had purchased from the ministry.
He bought a huge container that put him in the market, and then it was a problem because he even entered the Houses of Health”, she said.
Brovina says the health commission has long noted the supply of this insulin, she says it is not known why it has been supplied with this insulin, except that the price may have been the reason.
Maybe we've learned late when we were in Endocrinology, so we noticed that it was purchased insulin from Poland, it seems to me that insulin that didn't be used by the Balkan countries, and that is, it's exceeded them, it's been the price or don't know what it was”, Brovina told me about the Institute.
Brovina has admitted that the Endocrinology Clinic has not accepted this insulin, but only family, but that they have encountered many observations and many patients have refused to use this insulin.
Endocrinologists Bardil Gashi and Luan Goula in November last year had complained to the parliamentary Commission for Health for Biosemilary Insulina.












